Military Industry Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Military Industry Today.

Press releases published on October 5, 2026

Oct. 5, 2026

PMV Pharmaceuticals Appoints Matt Eckler, Ph.D., to Board of Directors

Indeterminate GlobeNewswire

Oct. 5, 2026

Gate Bioscience Expands Collaboration and License Agreement with Lilly to Target Difficult-to-Drug Proteins

Indeterminate GlobeNewswire

Oct. 5, 2026

Vortex Energy Commissions Hydrogen and Helium Study at Robinsons River Salt Project

Indeterminate GlobeNewswire

Oct. 5, 2026

4DMT to Host Investor Day on October 21, 2026

Indeterminate GlobeNewswire

Oct. 5, 2026

Trasteel Holding S.A., Through Newly Established Trasteel Magona, Takes Over Operations of La Magona d’Italia Steel Plant in Piombino, Italy

Indeterminate GlobeNewswire

Oct. 5, 2026

Baird Medical Highlights Global Expansion and Strategic Progress During Third Quarter 2026

Indeterminate GlobeNewswire

Oct. 5, 2026

Revolution Medicines Begins Treating Patients in Phase 3 RASolute 309 Trial Evaluating RASONQUE™ (daraxonrasib) Plus Zoldonrasib as First-Line Treatment for Metastatic RAS G12D Pancreatic Cancer

Indeterminate GlobeNewswire

Oct. 5, 2026

MAPS and International Alliance of Psychedelic Therapy Practitioners Announce Partnership to Advance Training for Psychedelic-Assisted Therapy

Indeterminate GlobeNewswire

Oct. 5, 2026

Aeroplan Members Can Multiply Their Impact for Children Travelling for Essential Medical Care During Points Matching Week

Indeterminate GlobeNewswire

Oct. 5, 2026

Les membres Aéroplan peuvent multiplier la portée de leurs dons pendant la Semaine du jumelage des points pour les enfants qui doivent se déplacer en avion afin de recevoir des soins médicaux indispensables

Indeterminate GlobeNewswire

Oct. 5, 2026

Cerevance Appoints Karl Kieburtz, M.D., M.P.H., as Chief Medical Officer

Indeterminate GlobeNewswire

Oct. 5, 2026

OnCusp Therapeutics Announces Positive Phase 1b Data Evaluating its CDH6-Directed Antibody-Drug Conjugate, CUSP06, in Platinum-Resistant Ovarian Cancer (PROC) Presented at Plenary Oral Session of the IGCS 2026 Annual Global Meeting

Indeterminate GlobeNewswire

Oct. 5, 2026

Forward Therapeutics Announces Positive Phase 1 Data for Potential Best-in-Class Oral TNFR1 Signaling Inhibitor FT2109, Supporting Advancement into Phase 2 Development

Indeterminate GlobeNewswire

Oct. 5, 2026

Magnite to Announce Third Quarter 2026 Financial Results on November 4, 2026

Indeterminate GlobeNewswire

Oct. 5, 2026

Kratos Secures More Than $100 Million in Contracts for Space and Cyber Mission Capabilities

Indeterminate GlobeNewswire

Oct. 5, 2026

TELA Bio Announces 510(k) Clearance for Liora™ Monofilament Scaffold for Soft Tissue Reinforcement

Indeterminate GlobeNewswire

Oct. 5, 2026

Prime Medicine Announces First Patient Dosed in Global Phase 1/2 Clinical Trial of PM577a for H1069Q-Mutated Wilson Disease

Indeterminate GlobeNewswire

Oct. 5, 2026

Sofwave to Participate in the Jefferies Private MedTech Virtual Summit

Indeterminate GlobeNewswire

Oct. 5, 2026

Rani Therapeutics Announces Acceptance into U.S. FDA's Emerging Technology Program (ETP)

Indeterminate GlobeNewswire

Oct. 5, 2026

vTv Therapeutics Announces Completion of Enrollment in Phase 3 CATT1 Study of Cadisegliatin in Type 1 Diabetes (T1D)

Indeterminate GlobeNewswire